Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Multicenter Retrospective Cohort Study on Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06498310

Acronym

IMI-CART

Enrollment

100

Registered

2024-07-12

Start date

2023-11-08

Completion date

2025-11-08

Last updated

2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Fungal Infections

Keywords

Invasive Fungal Infections, Filamentous fungi, Heart transplant, Fungal infections

Brief summary

Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patient ≥18 years old * Heart transplant * Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022 * Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria (20): * Invasive aspergillosis * Mucormycosis * Fusarium wilt * Scedosporiosis * Other filamentous fungus infection * Subject who has not expressed, after information, his opposition to the reuse of his data for the purposes of this research.

Exclusion criteria

* Patient having expressed his opposition to participating in the study * Patient not having a liver transplant * Subject under guardianship, curatorship or safeguard of justice.

Design outcomes

Primary

Measure	Time frame	Description
To identify the incidence, risk factors and prognostic factors associated with invasive fungal infections caused by filamentous fungi in heart transplant patients.	Up to 2 years	1. Incidence: number of cases of invasive fungal infection compared to the number of heart transplant patients per year in the study centers 2. Risk factors: Case-control study. Clinical, microbiological or radiological factors statistically associated with cases of invasive fungal infection compared to controls. 3. Prognostic factors: Clinical, microbiological or radiological factors of invasive fungal infections associated with mortality at the 12th week.

Countries

France

Contacts

Primary ContactFrançois DANION, MD

francois.danion@chru-strasbourg.fr33 3 69 55 15 88

Outcome results